Immunovant Stock Options Expiring on 17th of April 2025
| IMVT Stock | USD 28.73 1.57 5.78% |
Immunovant's latest option contracts expiring on 2025-04-17 are carrying combined implied volatility of 0.23 with a put-to-call open interest ratio of 4.33 over 31 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on 2025-04-17. The total put volume is at 159, with calls trading at the volume of 159. This yields a 0.75 put-to-call volume ratio.
Open Interest Against 2025-04-17 Option Contracts
Immunovant option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Immunovant's lending market. For example, when Immunovant's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Immunovant, he or she must hedge the risk by shorting Immunovant stock over its option's life.
2025-04-17
The chart above shows Immunovant's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Immunovant's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Immunovant's option, there is no secondary market available for investors to trade.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunovant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. Immunovant In The Money Call Balance
When Immunovant's strike price is surpassing the current stock price, the option contract against Immunovant stock is said to be in the money. When it comes to buying Immunovant's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Immunovant are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Immunovant Current Options Market Mood
Immunovant's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Immunovant Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Immunovant's options investors are not very successful. Immunovant's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Immunovant contract
Base on the Rule 16, the options market is currently suggesting that Immunovant will have an average daily up or down price movement of about 0.0144% per day over the life of the 2025-04-17 option contract. With Immunovant trading at USD 28.73, that is roughly USD 0.00413. If you think that the market is fully incorporating Immunovant's daily price movement you should consider buying Immunovant options at the current volatility level of 0.23%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Immunovant |
Immunovant Option Chain
When Immunovant's strike price is surpassing the current stock price, the option contract against Immunovant stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Immunovant's option chain is a display of a range of information that helps investors for ways to trade options on Immunovant. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Immunovant. It also shows strike prices and maturity days for a Immunovant against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | IMVT Option Call 17-04-2025 27 | 0 | 2025-04-17 | 0.0 - 0.0 | 9.3 | In |
Call | IMVT Option Call 17-04-2025 28 | 16 | 2025-04-17 | 7.2 - 8.9 | 7.0 | In |
Call | IMVT Option Call 17-04-2025 29 | 4 | 2025-04-17 | 6.6 - 9.4 | 7.0 | Out |
Call | IMVT Option Call 17-04-2025 30 | 0 | 2025-04-17 | 0.0 - 0.0 | 4.9 | |
Call | IMVT Option Call 17-04-2025 31 | 0 | 2025-04-17 | 0.0 - 0.0 | 4.6 | |
Call | IMVT Option Call 17-04-2025 32 | 0 | 2025-04-17 | 0.0 - 0.0 | 4.6 | |
Call | IMVT Option Call 17-04-2025 33 | 0 | 2025-04-17 | 0.0 - 0.0 | 4.2 | |
Call | IMVT Option Call 17-04-2025 34 | 0 | 2025-04-17 | 0.0 - 0.0 | 4.78 | |
Call | IMVT Option Call 17-04-2025 35 | 0 | 2025-04-17 | 0.0 - 0.0 | 5.6 | |
Call | IMVT Option Call 17-04-2025 36 | 0 | 2025-04-17 | 0.0 - 0.0 | 3.78 | |
Call | IMVT Option Call 17-04-2025 37 | 0 | 2025-04-17 | 0.0 - 0.0 | 4.45 | |
Call | IMVT Option Call 17-04-2025 38 | 10 | 2025-04-17 | 3.6 - 4.8 | 5.1 | Out |
Call | IMVT Option Call 17-04-2025 39 | 0 | 2025-04-17 | 0.0 - 0.0 | 2.23 | |
Call | IMVT Option Call 17-04-2025 45 | 0 | 2025-04-17 | 0.0 - 0.0 | 2.05 | |
Put | IMVT Option Put 17-04-2025 15 | 0 | 2025-04-17 | 0.0 - 0.0 | 0.7 | |
Put | IMVT Option Put 17-04-2025 20 | 0 | 2025-04-17 | 0.0 - 0.0 | 1.42 | |
Put | IMVT Option Put 17-04-2025 21 | 0 | 2025-04-17 | 0.0 - 0.0 | 1.75 | |
Put | IMVT Option Put 17-04-2025 22 | 0 | 2025-04-17 | 0.0 - 0.0 | 2.27 | |
Put | IMVT Option Put 17-04-2025 23 | 0 | 2025-04-17 | 0.0 - 0.0 | 2.4 | |
Put | IMVT Option Put 17-04-2025 24 | 0 | 2025-04-17 | 0.0 - 0.0 | 2.75 | |
Put | IMVT Option Put 17-04-2025 25 | 0 | 2025-04-17 | 0.0 - 0.0 | 4.5 | |
Put | IMVT Option Put 17-04-2025 27 | 39 | 2025-04-17 | 5.4 - 8.0 | 3.9 | Out |
Put | IMVT Option Put 17-04-2025 28 | 0 | 2025-04-17 | 0.0 - 0.0 | 7.5 | |
Put | IMVT Option Put 17-04-2025 29 | 0 | 2025-04-17 | 0.0 - 0.0 | 5.2 | In |
Put | IMVT Option Put 17-04-2025 30 | 0 | 2025-04-17 | 0.0 - 0.0 | 5.6 | In |
Put | IMVT Option Put 17-04-2025 31 | 0 | 2025-04-17 | 0.0 - 0.0 | 6.2 | In |
Put | IMVT Option Put 17-04-2025 32 | 0 | 2025-04-17 | 0.0 - 0.0 | 6.6 | In |
Put | IMVT Option Put 17-04-2025 33 | 56 | 2025-04-17 | 6.9 - 7.7 | 7.3 | In |
Put | IMVT Option Put 17-04-2025 34 | 0 | 2025-04-17 | 0.0 - 0.0 | 7.6 | In |
Put | IMVT Option Put 17-04-2025 35 | 0 | 2025-04-17 | 0.0 - 0.0 | 8.7 | In |
Put | IMVT Option Put 17-04-2025 40 | 35 | 2025-04-17 | 10.7 - 13.8 | 12.94 | In |
Immunovant Total Stockholder Equity
Total Stockholder Equity |
|
Immunovant Corporate Management
| MD MBA | Executive Board | Profile | |
| Jay Stout | Chief Officer | Profile | |
| Mark JD | Chief Secretary | Profile | |
| Julia Butchko | Chief Officer | Profile | |
| Andy Deig | Senior Finance | Profile | |
| Mark Levine | Chief Secretary | Profile | |
| Lauren MBA | Vice Marketing | Profile |
Additional Tools for Immunovant Stock Analysis
When running Immunovant's price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.